Clinical Trial Update: Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on prophylaxis for COVID-19 in healthcare workers using intensive treatment with ivermectin and iota-carrageenan (Phase 1/2; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars

Drugs mentioned

• IVERMECTIN (Ivermectin)
• iota-carrageenan (iota-carrageenan)

Snippet

Sponsor: Maria de los Angeles Peral de Bruno | Conditions: Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 1, Phase 2 | Status: COMPLETED